Press Release: European Medicines Agency update on the safety of Tamiflu

Author (Corporate)
Series Title
Series Details EMEA/385013/2005 (17.11.05)
Publication Date 17/11/2005
Content Type

Tamiflu is an antiviral approved in the European Union for the treatment of influenza in children between the ages of 1 and 13 years of age and for the prevention and treatment of influenza in adolescents over 13 years and adults.
Source Link http://www.emea.europa.eu/pdfs/general/direct/pr/38501305en.pdf
Related Links
EMA: Human medicines: European public assessment report: Tamiflu (Oseltamivir) http://www.emea.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000402/human_med_001075.jsp&mid=WC0b01ac058001d124
Subject Categories
Countries / Regions